$38.02
Value $1.5B
AMN and BA stock compared: price, dividend, valuation and results, from SEC filings.
$38.02
Value $1.5B
$171.50
Value $135B
AMN Healthcare Services (AMN) has a market value of $1.5B and Boeing (BA) $135B. Over the last year, with dividends, AMN moved +129.2% and BA -12.3%. The P/E is 13.5 for AMN and 18.4 for BA.
The main figures of both. A bar only shows which number is larger, not which is better.
Market value
AMN$1.5B
BA$135B
BA is 92 times AMN
Revenue, 12 months
AMN$3.5B
BA$94.9B
BA is 27 times AMN
Net income, 12 months
AMN$109M
BA$7.7B
BA is 70 times AMN
Operating margin
AMN5.8%
BA10.3%
4.5 points apart
ROIC
AMN8.9%
BA14.7%
5.8 points apart
P/E
AMN13.5
BA18.4
BA is 1.4 times AMN
Dividend yield
AMN0.0%
BA0.0%
About the same
5-year return
AMN-65.5%
BA-22.4%
43.1 points apart
A fainter bar means a negative number. The 5-year return includes dividends.
Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.
AMN-65.5%
BA-22.4%
| Period | AMNWith dividends | BAWith dividends |
|---|---|---|
| 1 year since November 12, 2025 | +129.2%Price +129.2% | -12.3%Price -12.3% |
| 3 years since November 13, 2023 | -34.6%-13.2% a yearPrice -34.6% | -16.2%-5.7% a yearPrice -16.2% |
| 5 years since November 12, 2021 | -65.5%-19.2% a yearPrice -65.5% | -22.4%-4.9% a yearPrice -22.4% |
| 10 years since November 14, 2016 | +22.4%+2.0% a yearPrice +22.4% | +23.4%+2.1% a yearPrice +14.3% |
Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.
As on each company's page. A description, not a recommendation: no one figure says which is better.
AMNAMN Healthcare ServicesBABoeing
| Price | $38.02 | $171.50 |
|---|---|---|
| Market value | $1.5B | $135B |
| Enterprise value (EV) | $2.0B | $160B |
| P/E | 13.5 | 18.4 |
| P/E, 5-year median | 14.0 | – |
| P/B | 1.9 | 20.6 |
| EV/EBIT | 9.7 | 16.4 |
| Free cash flow yield | 22.3% | 0.0% |
| Revenue, 12 months | $3.5B | $94.9B |
|---|---|---|
| Net income, 12 months | $109M | $7.7B |
| Free cash flow, 12 months | $327M | $16M |
| Earnings per share, 12 months | $2.76 | $9.69 |
| Revenue growth, year on year | -8.5% | 34.5% |
| Revenue growth a year, past | +2.7%over 5 years | +9.0%over 5 years |
| EPS growth a year, past | – | – |
| Gross margin | 28.4% | 9.4% |
|---|---|---|
| Operating margin | 5.8% | 10.3% |
| Net margin | 3.1% | 8.1% |
| ROIC | 8.9% | 14.7% |
| ROE | 15.5% | 241.7% |
| Cash | $256M | $20.7B |
|---|---|---|
| Total debt | $775M | $45.9B |
| Net debt / EBITDA | 1.4 | 2.2 |
| Interest cover | 6.1× | 4.0× |
| Dividend yield | – | – |
|---|---|---|
| Dividend per share, 12 months | – | – |
| Dividend growth a year, past | – | – |
| Buyback yield | – | – |
| Shareholder yield | – | – |
Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.
By market value, Boeing ($135B) is about 91.7 times AMN Healthcare Services ($1.5B), at today's prices.
Since November 14, 2016, AMN's price moved +22.4% and BA's +14.3%. With dividends: AMN +22.4% (+2.0% a year), BA +23.4% (+2.1% a year). Past returns do not predict future ones.
Neither paid a dividend over the last twelve months: AMN Healthcare Services and Boeing return money to shareholders, if they do, in other ways, such as buybacks.
At today's price, the P/E is 13.5 for AMN and 18.4 for BA. It is the share price over the last twelve months' earnings per share.
Over the last twelve months, the net margin was 3.1% for AMN Healthcare Services and 8.1% for Boeing, and the operating margin 5.8% and 10.3%. Revenue was $3.5B and $94.9B.
The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.
With each of the two, and with the largest in its sector.
The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.
Descriptive data from SEC filings and market prices.